Mast cells determine the magnitude of bacterial toxin-induced skin inflammation

Experimental Dermatology

Volumn 18, Issue 2, 2009, Pages 160-166

  Metz, Martin ^a   Magerl, Markus ^a   Kühl, Nele F ^a   Valeva, Angela ^b   Bhakdi, Sucharit ^b   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Bacterial infection; Chronic inflammation; Chronic urticaria; Innate immunity; Mast cells

Indexed keywords

ALPHA TOXIN; BACTERIAL TOXIN; STREPTOLYSIN O;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PERITONEUM MAST CELL; SKIN INFECTION; SKIN INFLAMMATION;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; DERMATITIS; DISEASE MODELS, ANIMAL; HEMOLYSIN PROTEINS; IMMUNE SYSTEM; INJECTIONS, INTRADERMAL; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PERITONEUM; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOLYSINS;

EID: 58249135995     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00778.x     Document Type: Article

References (50)

1. Marshall J S. Mast-cell responses to pathogens. Nat Rev Immunol 2004: 4: 787-799.
2. Galli S J, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005: 6: 135-142.
3. Metz M, Maurer M. Mast cells -key effector cells in immune responses. Trends Immunol 2007: 28: 234-241.
4. Echtenacher B, Männel D N, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996: 381: 75-77.
5. Malaviya R, Ikeda T, Ross E, Abraham S N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996: 381: 77-80.
6. Maurer M, Echtenacher B, Hültner L et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 1998: 188: 2343-2348.
7. Orinska Z, Maurer M, Mirghomizadeh F et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med 2007: 13: 927-934.
8. Malaviya R, Abraham S N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol 2000: 67: 841-846.
9. Metz M, Grimbaldeston M A, Nakae S, Piliponsky A M, Tsai M, Galli S J. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007: 217: 304-328.
10. Maurer M, Wedemeyer J, Metz M et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004: 432: 512-516.
11. Piliponsky A M, Chen C C, Nishimura T et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med 2008: 14: 392-398.
12. Schröder J M, Reich K, Kabashima K et al. Who is really in control of skin immunity under physiological circumstances-lymphocytes, dendritic cells or keratinocytes? Exp Dermatol 2006: 15: 913-929.
13. Siebenhaar F, Syska W, Weller K et al. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol 2007: 170: 1910-1916.
14. Bhakdi S, Bayley H, Valeva A et al. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: Prototypes of pore-forming bacterial cytolysins. Arch Microbiol 1996: 165: 73-79.
15. Walev I, Bhakdi S C, Hofmann F et al. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A 2001: 98: 3185-3190.
16. Valeva A, Hellmann N, Walev I et al. Evidence that clustered phosphocholine head groups serve as sites for binding and assembly of an oligomeric protein pore. J Biol Chem 2006: 281: 26014-26021.
17. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, Bhakdi S. Novel path to apoptosis: Small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 1994: 62: 1304-1312.
18. Walev I, Martin E, Jonas D et al. Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect Immun 1993: 61: 4972-4979.
19. Chiller K, Selkin B A, Murakawa G J. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 2001: 6: 170-174.
20. Galli S J, Kitamura Y. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol 1987: 127: 191-198.
21. Nakano T, Sonoda T, Hayashi C et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/W v mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985: 162: 1025-1043.
22. Palmer M, Jursch R, Weller U et al. Staphylococcus aureus alpha-toxin. Production of functionally intact, site-specifically modifiable protein by introduction of cysteine at positions 69, 130, and 186. J Biol Chem 1993: 268: 11959-11962.
23. Weller U, Muller L, Messner M et al. Expression of active streptolysin O in Escherichia coli as a maltose-binding-protein-streptolysin-O fusion protein. The N-terminal 70 amino acids are not required for hemolytic activity. Eur J Biochem 1996: 236: 34-39.
24. Choi O, Yahiro K, Morinaga N, Miyazaki M, Noda M. Inhibitory effects of various plant polyphenols on the toxicity of Staphylococcal alpha-toxin. Microb Pathog 2007: 42: 215-224.
25. Boesiger J, Tsai M, Maurer M et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 1998: 188: 1135-1145.
26. Metz M, Botchkarev V A, Botchkareva N V et al. Neurotrophin-3 regulates mast cell functions in neonatal mouse skin. Exp Dermatol 2004: 13: 273-281.
27. Wershil B K, Murakami T, Galli S J. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol 1988: 140: 2356-2360.
28. Siebenhaar F, Magerl M, Peters E M J, Hendrix S, Metz M, Maurer M. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J Allergy Clin Immunol 2008: 121: 955-961.
29. Lindau M, Gomperts B D. Techniques and concepts in exocytosis: Focus on mast cells. Biochim Biophys Acta 1991: 1071: 429-471.
30. Howell T W, Gomperts B D. Rat mast cells permeabilised with streptolysin O secrete histamine in response to Ca2+ at concentrations buffered in the micromolar range. Biochim Biophys Acta 1987: 927: 177-183.
31. Stassen M, Müller C, Richter C et al. The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase- and protein kinase C-dependent pathways. Infect Immun 2003: 71: 6171-6177.
32. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev 1991: 55: 733-751.
33. Engel F, Blatz R, Schliebs R, Palmer M, Bhakdi S. Bacterial cytolysin perturbs round window membrane permeability barrier in vivo: Possible cause of sensorineural hearing loss in acute otitis media. Infect Immun 1998: 66: 343-346.
34. Nilsson I M, Hartford O, Foster T, Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 1999: 67: 1045-1049.
35. Limbago B, Penumalli V, Weinrick B, Scott J R. Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun 2000: 68: 6384-6390.
36. Metz M, Lammel V, Gibbs B F, Maurer M. Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. Am J Pathol 2006: 169: 815-822.
37. Grimbaldeston M A, Nakae S, Kalesnikoff J, Tsai M, Galli S J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007: 8: 1095-1104.
38. Maurer M, Lopez Kostka S, Siebenhaar F et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 2006: 20: 2460-2467.
39. Metz M, Piliponsky A M, Chen C C et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006: 313: 526-530.
40. Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008: 213: 251-260.
41. Henz B M. Exploring the mast cell enigma: A personal reflection of what remains to be done. Exp Dermatol 2008: 17: 91-99.
42. Ikeda T, Funaba M. Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol Lett 2003: 88: 21-26.
43. Qiao H, Andrade M V, Lisboa F A, Morgan K, Beaven M A. FcεR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006: 107: 610-618.
44. Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004: 173: 531-541.
45. Malaviya R, Abraham S N. Mast cell modulation of immune responses to bacteria. Immunol Rev 2001: 179: 16-24.
46. Galli S J, Maurer M, Lantz C S. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999: 11: 53-59.
47. Maurer M, Metz M. The status quo and quo vadis of mast cells. Exp Dermatol 2005: 14: 923-929.
48. Breuer K, Wittmann M, Kempe K et al. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 2005: 35: 1088-1095.
49. Kapetanovic R, Cavaillon J M. Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther 2007: 7: 907-918.
50. Tan T T, Coussens L M. Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007: 19: 209-216.